Hisamitsu Pharmaceutical Co., Inc.
HTSUF · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | $306,394 | $338,800 | $270,290 | $269,594 |
| - Cash | $103,921 | $104,107 | $114,518 | $102,512 |
| + Debt | $2,377 | $2,646 | $3,856 | $2,928 |
| Enterprise Value | $204,850 | $237,339 | $159,628 | $170,010 |
| Revenue | $40,278 | $34,665 | $44,753 | $35,797 |
| % Growth | 16.2% | -22.5% | 25% | – |
| Gross Profit | $24,806 | $21,286 | $24,808 | $21,979 |
| % Margin | 61.6% | 61.4% | 55.4% | 61.4% |
| EBITDA | $6,512 | $0 | $7,259 | $5,709 |
| % Margin | 16.2% | 0% | 16.2% | 15.9% |
| Net Income | $4,458 | $2,564 | $8,098 | $4,562 |
| % Margin | 11.1% | 7.4% | 18.1% | 12.7% |
| EPS Diluted | 61.99 | 35.1 | 110.82 | 62.22 |
| % Growth | 76.6% | -68.3% | 78.1% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |